[go: up one dir, main page]

MX9205637A - Metodo para prevenir el rechazo de aloinjertos. - Google Patents

Metodo para prevenir el rechazo de aloinjertos.

Info

Publication number
MX9205637A
MX9205637A MX9205637A MX9205637A MX9205637A MX 9205637 A MX9205637 A MX 9205637A MX 9205637 A MX9205637 A MX 9205637A MX 9205637 A MX9205637 A MX 9205637A MX 9205637 A MX9205637 A MX 9205637A
Authority
MX
Mexico
Prior art keywords
aloinjertos
rejection
prevent
Prior art date
Application number
MX9205637A
Other languages
English (en)
Inventor
Mitsuaki Isobe
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of MX9205637A publication Critical patent/MX9205637A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
MX9205637A 1991-10-01 1992-10-01 Metodo para prevenir el rechazo de aloinjertos. MX9205637A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76804491A 1991-10-01 1991-10-01

Publications (1)

Publication Number Publication Date
MX9205637A true MX9205637A (es) 1993-05-01

Family

ID=25081356

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205637A MX9205637A (es) 1991-10-01 1992-10-01 Metodo para prevenir el rechazo de aloinjertos.

Country Status (8)

Country Link
EP (1) EP0610298A1 (es)
JP (1) JPH07502727A (es)
AU (1) AU667487B2 (es)
CA (1) CA2120500A1 (es)
HU (1) HUT69725A (es)
MX (1) MX9205637A (es)
WO (1) WO1993006864A1 (es)
ZA (1) ZA927503B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764681B2 (en) 1991-10-07 2004-07-20 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
JPH07506566A (ja) * 1992-02-12 1995-07-20 バイオゲン　インコーポレイテッド 炎症性胃腸病の処置
DK0656789T3 (da) * 1992-08-21 1998-08-24 Genentech Inc Fremgangsmåde til behandling af en LFA-1-medieretforstyrrelse.
US5817515A (en) * 1993-12-23 1998-10-06 Icos Corporation Human B2 integrin alpha subunit antibodies
US6670321B1 (en) 1998-12-30 2003-12-30 The Children's Medical Center Corporation Prevention and treatment for retinal ischemia and edema
WO2001051084A1 (en) * 2000-01-14 2001-07-19 Genentech, Inc. Diagnosis and treatment of hepatic inflammatory disorders by inhibiting the binding of lfa-1 to icam-1
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
AU2002320352A1 (en) 2001-07-24 2003-02-17 Biogen Idec Ma Inc. Methods for treating or preventing sclerotic disorders using cd2-binding agents
CA2565259A1 (en) 2004-05-07 2005-12-08 Astellas Us Llc Soluble lfa-3 polypeptide for treating viral disorders
WO2005123777A2 (en) 2004-06-09 2005-12-29 Genentech, Inc. Method of treating granuloma annulare or sarcoid
WO2008140484A2 (en) 2006-11-09 2008-11-20 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2064327T3 (es) * 1987-11-02 1995-02-01 Baylor College Medicine Uso de icam-1 o de sus derivados funcionales para el tratamiento de una inflamacion no especifica.
ATE125708T1 (de) * 1988-09-28 1995-08-15 Dana Farber Cancer Inst Inc Interzellulare adhäsions-moleküle und deren bindungsliganden.
EP0534944B1 (en) * 1988-11-14 1996-09-11 Brigham And Women's Hospital Antibodies specific for elam-1 and the use thereof
ATE79270T1 (de) * 1989-03-09 1992-08-15 Boehringer Ingelheim Pharma Verwendung von interzellularen adhaesionsmolek¨len und deren bindungsliganden bei der behandlung von asthma.
ZA903223B (en) * 1989-04-28 1991-02-27 Baylor College Medicine Dissemination of hiv-1 infected cells
US5011778A (en) * 1989-05-23 1991-04-30 Otsuka Pharmaceutical Co., Ltd. Monoclonal antibodies directed to IL-1 activated endothelial cells and medicaments employing the monoclonal antibodies
GB9009549D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Recombinant antibody and method
GB9009548D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method

Also Published As

Publication number Publication date
AU667487B2 (en) 1996-03-28
JPH07502727A (ja) 1995-03-23
EP0610298A1 (en) 1994-08-17
HUT69725A (en) 1995-09-28
ZA927503B (en) 1993-05-03
HU9400930D0 (en) 1994-06-28
AU2782992A (en) 1993-05-03
WO1993006864A1 (en) 1993-04-15
CA2120500A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
MX9206450A (es) Proceso para la produccion de isoleucina-l.
MX9203870A (es) Metodo para la produccion de granulos.
FI914695A7 (fi) Niittain
AR244238A1 (es) Proceso para la preparacion de n-alquil polihidroxi aminas.
DE69206353D1 (de) Anlasser.
FR2663549B1 (fr) Mousqueton autoverrouillant.
FI913048A0 (fi) Bicykliska heterocykliska foereningar.
DE69100450D1 (de) Gefrierölzusammensetzung.
MX9207008A (es) Medicamentos para el tratamiento de condiciones inflamatorias o para la analgesia.
MX9206442A (es) Metodo para el aumento de la produccion de larvas de crustaceos.
FR2691219B1 (fr) Coussinet de palier.
MX9205637A (es) Metodo para prevenir el rechazo de aloinjertos.
MX9203919A (es) Procedimiento para purificar organopolisiloxanos.
AT370486B (de) Schliesszylinder od.dgl.
MX9205285A (es) Alojamiento para colocar piezas de trabajo para maquinado y metodo para fabricar y separar el alojamiento.
FI902811A7 (fi) Ariadnetraoden.
FI894921A0 (fi) Anordning foer foertunnande av kanten vid en kartongbana eller -ark.
DE3860364D1 (de) Brausestange.
FR2663550B1 (fr) Descendeur autobloquant.
FR2657403B1 (fr) Ecrou anti-jeu.
MX9200872A (es) Composicion de bis-bibenzimidazol.
AT371344B (de) Ski od.dgl.
ES2019583B3 (es) Composicion para el tratamiento de infecciones.
ES1004803Y (es) Dispositivo para el montaje de cercas para piscicultura.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.